CN103254075A - 氟比洛芬酯的制备方法 - Google Patents
氟比洛芬酯的制备方法 Download PDFInfo
- Publication number
- CN103254075A CN103254075A CN201310079429XA CN201310079429A CN103254075A CN 103254075 A CN103254075 A CN 103254075A CN 201310079429X A CN201310079429X A CN 201310079429XA CN 201310079429 A CN201310079429 A CN 201310079429A CN 103254075 A CN103254075 A CN 103254075A
- Authority
- CN
- China
- Prior art keywords
- flurbiprofen
- preparation
- organic solvent
- washing
- flurbiprofen axetil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ALIVXCSEERJYHU-UHFFFAOYSA-N Flurbiprofen axetil Chemical compound FC1=CC(C(C)C(=O)OC(OC(C)=O)C)=CC=C1C1=CC=CC=C1 ALIVXCSEERJYHU-UHFFFAOYSA-N 0.000 title claims abstract description 53
- 229950005941 flurbiprofen axetil Drugs 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 43
- 239000003960 organic solvent Substances 0.000 claims abstract description 33
- 238000005406 washing Methods 0.000 claims abstract description 28
- 238000001035 drying Methods 0.000 claims abstract description 21
- 239000002904 solvent Substances 0.000 claims abstract description 21
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- 229960002390 flurbiprofen Drugs 0.000 claims abstract description 17
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 claims abstract description 16
- 238000004821 distillation Methods 0.000 claims abstract description 15
- 239000003054 catalyst Substances 0.000 claims abstract 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 57
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 36
- 235000019439 ethyl acetate Nutrition 0.000 claims description 19
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 18
- 235000017550 sodium carbonate Nutrition 0.000 claims description 18
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 16
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 15
- 229910052783 alkali metal Inorganic materials 0.000 claims description 15
- RJCQBQGAPKAMLL-UHFFFAOYSA-N bromotrifluoromethane Chemical compound FC(F)(F)Br RJCQBQGAPKAMLL-UHFFFAOYSA-N 0.000 claims description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 12
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 11
- -1 alkali metal acetate Chemical class 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 11
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 238000002347 injection Methods 0.000 claims description 10
- 239000007924 injection Substances 0.000 claims description 10
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 8
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 6
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 6
- 150000001340 alkali metals Chemical class 0.000 claims description 6
- 239000004005 microsphere Substances 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 235000017281 sodium acetate Nutrition 0.000 claims description 6
- 239000001632 sodium acetate Substances 0.000 claims description 6
- 235000002639 sodium chloride Nutrition 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 5
- 239000001488 sodium phosphate Substances 0.000 claims description 5
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 5
- 235000011008 sodium phosphates Nutrition 0.000 claims description 5
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 5
- 229910000318 alkali metal phosphate Inorganic materials 0.000 claims description 4
- 239000007789 gas Substances 0.000 claims description 4
- 150000002632 lipids Chemical class 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 229960002668 sodium chloride Drugs 0.000 claims description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 3
- 239000011261 inert gas Substances 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 2
- 235000019800 disodium phosphate Nutrition 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 2
- 229940093916 potassium phosphate Drugs 0.000 claims description 2
- 235000011009 potassium phosphates Nutrition 0.000 claims description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 1
- 235000015320 potassium carbonate Nutrition 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 abstract description 2
- RGHQKFQZGLKBCF-UHFFFAOYSA-N 2-bromoethyl acetate Chemical compound CC(=O)OCCBr RGHQKFQZGLKBCF-UHFFFAOYSA-N 0.000 abstract 1
- 239000004519 grease Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 8
- 239000002994 raw material Substances 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 6
- 239000012535 impurity Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 230000008030 elimination Effects 0.000 description 4
- 238000003379 elimination reaction Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000013583 drug formulation Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- ASTWEMOBIXQPPV-UHFFFAOYSA-K trisodium;phosphate;dodecahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[O-]P([O-])([O-])=O ASTWEMOBIXQPPV-UHFFFAOYSA-K 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
Images
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310079429.XA CN103254075B (zh) | 2013-03-13 | 2013-03-13 | 氟比洛芬酯的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310079429.XA CN103254075B (zh) | 2013-03-13 | 2013-03-13 | 氟比洛芬酯的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103254075A true CN103254075A (zh) | 2013-08-21 |
CN103254075B CN103254075B (zh) | 2014-05-14 |
Family
ID=48958349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310079429.XA Active CN103254075B (zh) | 2013-03-13 | 2013-03-13 | 氟比洛芬酯的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103254075B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105777544A (zh) * | 2016-04-13 | 2016-07-20 | 成都倍特药业有限公司 | 一种高光学纯度s-(+)-氟比洛芬酯的制备方法 |
CN107982248A (zh) * | 2017-12-01 | 2018-05-04 | 山西普德药业有限公司 | 一种氟比洛芬酯注射液的制备方法 |
CN109580788A (zh) * | 2017-09-28 | 2019-04-05 | 北京蓝贝望生物医药科技股份有限公司 | 拆分和测定氟比洛芬酯及s-氟比洛芬酯的方法 |
CN113912492A (zh) * | 2020-07-07 | 2022-01-11 | 宜昌人福药业有限责任公司 | 一种氟比洛芬酯的精制方法 |
CN114075109A (zh) * | 2020-08-21 | 2022-02-22 | 北京泰德制药股份有限公司 | 一种氟比洛芬酯的制备方法及制备的晶型 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102381970A (zh) * | 2011-12-08 | 2012-03-21 | 南京优科生物医药有限公司 | 一种制备氟比洛芬酯化合物的方法 |
-
2013
- 2013-03-13 CN CN201310079429.XA patent/CN103254075B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102381970A (zh) * | 2011-12-08 | 2012-03-21 | 南京优科生物医药有限公司 | 一种制备氟比洛芬酯化合物的方法 |
Non-Patent Citations (1)
Title |
---|
国大亮灯: "氟比洛芬酯的合成", 《齐鲁药事》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105777544A (zh) * | 2016-04-13 | 2016-07-20 | 成都倍特药业有限公司 | 一种高光学纯度s-(+)-氟比洛芬酯的制备方法 |
CN105777544B (zh) * | 2016-04-13 | 2018-11-02 | 成都倍特药业有限公司 | 一种s-(+)-氟比洛芬酯的制备方法 |
CN109580788A (zh) * | 2017-09-28 | 2019-04-05 | 北京蓝贝望生物医药科技股份有限公司 | 拆分和测定氟比洛芬酯及s-氟比洛芬酯的方法 |
CN109580788B (zh) * | 2017-09-28 | 2023-03-31 | 上海惠永药物研究有限公司 | 拆分和测定氟比洛芬酯及s-氟比洛芬酯的方法 |
CN107982248A (zh) * | 2017-12-01 | 2018-05-04 | 山西普德药业有限公司 | 一种氟比洛芬酯注射液的制备方法 |
CN113912492A (zh) * | 2020-07-07 | 2022-01-11 | 宜昌人福药业有限责任公司 | 一种氟比洛芬酯的精制方法 |
CN113912492B (zh) * | 2020-07-07 | 2023-07-11 | 宜昌人福药业有限责任公司 | 一种氟比洛芬酯的精制方法 |
CN114075109A (zh) * | 2020-08-21 | 2022-02-22 | 北京泰德制药股份有限公司 | 一种氟比洛芬酯的制备方法及制备的晶型 |
CN114075109B (zh) * | 2020-08-21 | 2024-05-03 | 北京泰德制药股份有限公司 | 一种氟比洛芬酯的制备方法及制备的晶型 |
Also Published As
Publication number | Publication date |
---|---|
CN103254075B (zh) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103254075B (zh) | 氟比洛芬酯的制备方法 | |
CN102143967B (zh) | 阿德福韦酯的纯化方法 | |
CN102329277A (zh) | 一种制备帕瑞昔布的方法 | |
CN104557800A (zh) | 2-苯氧基四氢呋(吡)喃衍生物及其在五氟磺草胺合成中的应用 | |
CN103304629A (zh) | 一种高光学纯度硼替佐米的制备方法及其中间体 | |
CN108997377B (zh) | 一种e型7-atca的制备方法 | |
CN104177372A (zh) | 抗结核候选药物pa-824的合成方法 | |
CN102942511A (zh) | 一种环戊二烯的制备方法 | |
JP6240346B2 (ja) | ロスバスタチンカルシウムを製造するための中間体化合物、及びそれを用いてロスバスタチンカルシウムを製造する方法 | |
CN104710347A (zh) | (r)-1-苄基-3-甲基-1,2,3,6-四氢哌啶的合成方法 | |
CN107501316B (zh) | 苯芴醇异构体及其制备方法 | |
CN110218160B (zh) | 一种奎宁酸衍生物及其制备方法与应用 | |
CN111574567B (zh) | 刚性杂环化合物及其制备方法和用途和含膦磺酰胺化合物及其制备方法 | |
Tang et al. | TMSOTf-catalyzed intramolecular seleno-arylation of tethered alkenes: A novel method for the solid-phase synthesis of dihydrocoumarins and coumarins | |
CN103012461B (zh) | 一种生物素关键中间体1,2-二(三甲基硅氧基)环己烯的制备方法 | |
RU2605936C1 (ru) | Способ получения диэфиров 5,7-диметил-3-карбокси-1-адамантилуксусной кислоты | |
RU2402564C2 (ru) | Способ получения n-пиразиноил-(l)-фенилаланил-(l)-лейцинбороновой кислоты или ее ангидрида | |
JPH08231491A (ja) | 1,3−ジシクロヘキシルカルボジイミドの製造方法 | |
CN104974188B (zh) | 一种替诺福韦酯晶型及其制备方法 | |
CN103288780A (zh) | 1-苯基-1-环戊基环氧乙烷的制备方法 | |
RU2483055C1 (ru) | Способ получения 1,5-бис(2-гидроксифенокси)-3-оксапентана моногидрата | |
CN111747873B (zh) | 一种艾瑞昔布中间体及其制备方法和用途 | |
RU2770434C1 (ru) | Способ простого и удобного получения ваборбактама | |
Gao et al. | Regioselective assembly of 3, 4-dihydroisoquinoline derivatives | |
CN110615814B (zh) | 一种半富马酸替诺福韦二吡呋酯的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 430000 Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Patentee after: Yuanda Life Science (Wuhan) Co.,Ltd. Address before: 430023 No. 1, Da'an Road, Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Patentee before: WUHAN DOCAN PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of flurbiprofen axetil Effective date of registration: 20220224 Granted publication date: 20140514 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: Yuanda Life Science (Wuhan) Co.,Ltd. Registration number: Y2022420000043 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230403 Granted publication date: 20140514 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: Yuanda Life Science (Wuhan) Co.,Ltd. Registration number: Y2022420000043 |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 430000 No.1 Xiaoxiang West Road, Dongxihu District, Wuhan City, Hubei Province Patentee after: Yuanda Medical Nutrition Science (Wuhan) Co.,Ltd. Country or region after: China Address before: 430000 Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Patentee before: Yuanda Life Science (Wuhan) Co.,Ltd. Country or region before: China |